Current Liabilities Alterar Data
AbbVie USD 34.77B 2.53B 2023-09
Acadia Pharmaceuticals USD 254.25M 44.65M 2023-12
ALKERMES USD 503.11M 15.92M 2023-09
Amgen USD 18.39B 1.44B 2023-12
Bayer EUR 33.08B 894M 2023-09
Biogen USD 3.43B 1.59B 2023-12
BioMarin Pharmaceutical USD 1.18B 13.8M 2023-12
Bluebird Bio USD 158.96M 23.94M 2023-09
Bristol-Myers Squibb USD 23.46B 3.31B 2023-09
Eli Lilly USD 22B 3.08B 2023-09
Esperion Therapeutics USD 137.71M 30.54M 2023-09
Gilead Sciences USD 11.28B 665M 2023-12
Incyte USD 1.24B 115.7M 2023-12
Intra Cellular Therapies USD 123.54M 20.45M 2023-12
Marinus Pharmaceuticals USD 30.56M 4.95M 2023-09
Merck USD 23.09B 300M 2023-09
Moderna USD 3.02B 1.37B 2023-12
Neurocrine Biosciences USD 691.6M 109.1M 2023-09
Pfizer USD 31.14B 3.51B 2023-09
PTC Therapeutics USD 603.1M 110.98M 2023-12
Regeneron Pharmaceuticals USD 4.4B 805.6M 2023-12
Sarepta Therapeutics USD 450.74M 47.91M 2023-09
Teva Pharmaceutical Industries USD 11.39B 449M 2023-09
Ultragenyx Pharmaceutical USD 253.98M 9.6M 2023-09
United Therapeutics USD 804.4M 60.3M 2023-12
Vertex Pharmaceuticals USD 3.6B 247.3M 2023-09



Biogen Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2024.